NEW YORK, NY / ACCESSWIRE / January 11, 2019 / U.S. markets finished in the green on Thursday, however gains were held back by a sharp decline in Macy’s shares that pressured retail stocks lower. The Dow Jones Industrial Average was up by 0.51 percent to close at 24,001.92, while S&P 500 gained 0.45 percent to settle at 2,596.64. Nasdaq increased 0.42 percent to close at 6,986.07.
According to TD Ameritrade’s Chief Market Strategist, JJ Kinahan, “Retailers are having a bad morning, and that’s obviously weighing on markets today.” However, the market appears to see this as a company-specific issue rather than a comment on the broader economy, and said that “the recent selloff was all about uncertainty over trade and growth.”
The Market Edge Initiates Coverage on:
Tandem Diabetes Care, Inc.
Tandem Diabetes Care's stock jumped 3.84% Thursday, to close the day at $42.20. The stock recorded a trading volume of 2,848,206 shares, which was above its three months average volume of 1,712,944 shares. In the last year, Tandem Diabetes Care's shares have traded in a range of 2.14 - 52.55. The share price has gained 1871.96% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $35.25 is above its 200-day moving average of $34.75. Shares of Tandem Diabetes Care have gained roughly 19.95 percent in the past month and are up 13.11 percent year-to-date.
Access The Market Edge's Tandem Diabetes Care, Inc. Research Report:
On Thursday, shares of Inogen recorded a trading volume of 305,439 shares, which was below the three months average volume of 484,335 shares. The stock ended the day 3.49% higher at $141.36. The share price has fallen 50.88% from its 52 week high with a 52 week trading range of 110.51 - 287.79. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $132.42 is below its 200-day moving average of $194.50. Shares of the company are trading at a Price to Earnings ratio of 76.74. Shares of Inogen have gained roughly 1.1 percent in the past month and are up 15.41 percent year-to-date.
Access The Market Edge's Inogen, Inc. Research Report:
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: The Market Edge